Steven Cohen’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding AVTX
Steven Cohen's AVTX Position: Q3 2026 in Review
Steven Cohen reduced its Avalo Therapeutics (AVTX) stake by 32% in Q3 2026, selling an estimated $14M and leaving 1,625,019 shares worth $24.9M. The position accounts for 0.03% of the portfolio, ranked #794.
Steven Cohen first reported a position in AVTX in Q1 2021 and has held it in 14 quarters since. The position peaked at $44.1M in Q2 2026. 145 funds tracked by Wall St. Rank hold AVTX as of Q3 2026.
- Steven Cohen held 1,625,019 shares of Avalo Therapeutics worth $24.9M as of Q3 2026.
- Steven Cohen sold 762,007 Avalo Therapeutics shares in Q3 2026, an estimated $14M.
- Avalo Therapeutics made up 0.03% of Steven Cohen's portfolio in Q3 2026, its #794 holding.
- Steven Cohen first reported a position in Avalo Therapeutics in Q1 2021 and has held it in 14 quarters since.
- Steven Cohen's Avalo Therapeutics position peaked at $44.1M in Q2 2026.
- 145 funds tracked by Wall St. Rank held Avalo Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.